Rights and permissions
About this article
Cite this article
NZ Pharmac to fund lapatinib and pazopanib. Pharmacoecon. Outcomes News 649, 10 (2012). https://doi.org/10.2165/00151234-201206490-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206490-00028